Managers
Noerr has advised Isaria Wohnbau on its capital increase carried out in connection with its takeover by the US private equity investor Lone Star.
The cash raised amounted to around EUR53 million.
At the same time, Noerr assisted the Munich-based project development company in cancelling the admission of its shares to trading on the regulated market of Frankfurt Stock Exchange.
This was the first withdrawal from the stock market under the new rules on delisting which have been in force since the end of 2015.
A team led by Noerr partners Dr Laurenz Wieneke and Dr Stephan
Early-stage venture capital firm True Ventures has raised USD310 million for its fifth fund, True Ventures V.
With the close of this fund, True now manages approximately USD1.3 billion in capital.
True received support from substantially all of its existing investor base and a few new institutional investors.
Celebrating its 10-year anniversary this year, True Ventures has enjoyed a consistent track record of success in multiple markets including connected hardware, enterprise software and infrastructure.
Successful investments include Fitbit (NYSE: FIT), MakerBot (acquired by Stratasys), Goodreads (acquired by Amazon), BrightRoll (acquired by Yahoo!), and Automattic (the company behind
Guardian Capital Partners has acquired Carson-Dellosa Publishing in partnership with the firm’s existing executive management team, which will continue operating the company going forward.
Headquartered in Greensboro, North Carolina, Carson-Dellosa is a provider of K-8 supplemental education content for parents, teachers and students with a portfolio of brands including Spectrum, Summer Bridge and Carson-Dellosa Education.
With 35 years of experience in the consumer educational products market, the company offers digital and print workbooks, test-prep, hands-on learning materials and classroom décor and resources.
Carson-Dellosa’s products are used in over 1,000 schools and can be purchased at over 10,000 retail
Funds managed by Alpina Partners have acquired Cimdata from Infoniqa Holding and iLab24.
Cimdata will now become part of a larger group of enterprise software businesses focusing on enterprise resource planning (ERP).
Alpina has previously acquired a majority stake in Oxaion, an ERP software company based in Ettlingen, Germany.
Terms of the transaction have not been disclosed.
“We are happy to welcome Cimdata as new member of our software buy-and-build platform. The company is a well-respected supplier of specialised ERP software solutions with a clear focus on the manufacturing industry,” says Florian Strehle, partner at Alpina Partners.
BioLineRx, a clinical stage biopharmaceutical company dedicated to identifying, in-licensing and developing new drugs, has established a joint venture (JV) with I-Bridge Capital, a Chinese venture capital fund focused on developing new therapies.
The joint venture, named iPharma, will develop clinical and pre-clinical therapeutic candidates originating primarily in Israel to serve the Chinese and global healthcare markets.
Under the terms of the JV agreement, each partner will provide seed capital of one million dollars to the venture. BioLineRx will screen and identify promising early-stage drug candidates originating primarily in Israel with emphasis on therapeutic indications that are of special
Capstone has advised Green Dot, a telecommunications provider headquartered in Trinidad and Tobago, on its deal to sell a 51 per cent stake to One Caribbean Media.
The acquisition will allow Green Dot to accelerate subscriber growth and continue expanding into new markets.
Green Dot, headquartered in Port of Spain, Trinidad and Tobago, is a licensed telecommunications operator offering wireless ISP and subscription TV services to residential and business customers in Trinidad and Tobago, Grenada, and Suriname.
OCM is a regional media group quoted on the stock exchanges of Trinidad and Tobago and Barbados under the ticker symbol
Equistone Partners-backed Travel Counsellors, an independent provider of bespoke leisure and corporate travel, has seen a 22 per cent rise in turnover over the last 12 months.
The Manchester-based company, which has been backed by the private equity house since 2014, has reported turnover of GBP166 million for the year ending October 2015 – up from GBP136 million the previous year.
This growth is attributed to the adoption of the latest technology to enhance its services. In particular, the business has seen a 13 per cent increase globally in sales made through its in-house quote and booking technology, which
Earlybird Venture Capital has held the first closing of its Earlybird Health Tech Fund.
Headquartered in North Rhine-Westphalia, the fund will invest primarily in the field of medical technology across Europe and has a target size of EUR100 million to EUR120 million.
The fund’s investors include NRW.BANK, the Generali Insurance Group, the German household and medical products manufacturer Miele, as well as the Federal Ministry for Economic Affairs and Energy with a share of the federally administered special fund of the European Recovery Program, the so-called ERP Fund.
For the first time in Germany, a public health insurer,
Antares Capital is serving as administrative agent and sole lead arranger on a USD72 million senior secured credit facility to support the acquisition of Pathway Partners Vet Holding by investment funds managed by Morgan Stanley Global Private Equity (MSPE).
Founded by Dr Jasen Trautwein in Austin, Texas and led by CEO Shawn McVey, Pathway is a veterinary hospital owner and operator.
Pathway owns over 30 general and specialty veterinary hospitals, providing systems and processes to enhance productivity and improve medical services while maintaining the practice’s local culture and community identity.
“The Antares team has delivered a financing structure
Octopus Investments, a provider of venture capital trusts (VCTs) in the UK, has launched a GBP70 million fundraise for Octopus Titan Venture Capital Trust.
With over GBP309 million in assets under management, Titan VCT is the largest VCT on the market and has a strong track record of delivering returns for investors.
Since it was first launched in 2007 it has focused on investing into early stage companies with the potential for high growth.
Today the VCT offers investors access to a well-established and diverse portfolio of around 50 smaller companies. These range from very young early stage
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
